Sagimet Biosciences Inc.
SGMT
$7.11
-$0.24-3.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.39M | -18.18M | -16.20M | -14.62M | -8.12M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.41M | 976.00K | 1.52M | 1.06M | 1.01M |
| Change in Net Operating Assets | -125.00K | 2.66M | 3.66M | -6.01M | 1.48M |
| Cash from Operations | -9.10M | -14.54M | -11.02M | -19.57M | -5.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -13.29M | 3.41M | 9.85M | 624.00K | -75.16M |
| Cash from Investing | -13.29M | 3.41M | 9.85M | 624.00K | -75.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.00K | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -27.00K |
| Cash from Financing | 1.00K | -- | 0.00 | 0.00 | -27.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -22.39M | -11.12M | -1.17M | -18.95M | -80.82M |